Tudor Investment Corp’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-2,327
| Closed | -$6K | – | 1462 |
|
|
2019
Q1 | $6K | Hold |
2,327
| – | – | ﹤0.01% | 1063 |
|
|
2018
Q4 | $5K | Hold |
2,327
| – | – | ﹤0.01% | 967 |
|
|
2018
Q3 | $11K | Hold |
2,327
| – | – | ﹤0.01% | 1043 |
|
|
2018
Q2 | $11K | Hold |
2,327
| – | – | ﹤0.01% | 998 |
|
|
2018
Q1 | $17K | Hold |
2,327
| – | – | ﹤0.01% | 949 |
|
|
2017
Q4 | $17K | Hold |
2,327
| – | – | ﹤0.01% | 1054 |
|
|
2017
Q3 | $19K | Hold |
2,327
| – | – | ﹤0.01% | 1043 |
|
|
2017
Q2 | $24K | Hold |
2,327
| – | – | ﹤0.01% | 985 |
|
|
2017
Q1 | $27K | Hold |
2,327
| – | – | ﹤0.01% | 1336 |
|
|
2016
Q4 | $30K | Hold |
2,327
| – | – | ﹤0.01% | 1327 |
|
|
2016
Q3 | $43K | Hold |
2,327
| – | – | ﹤0.01% | 1360 |
|
|
2016
Q2 | $25K | Hold |
2,327
| – | – | ﹤0.01% | 1393 |
|
|
2016
Q1 | $44K | Hold |
2,327
| – | – | ﹤0.01% | 1421 |
|
|
2015
Q4 | $62K | Buy |
2,327
+495
| +27% | +$13.2K | ﹤0.01% | 1416 |
|
|
2015
Q3 | $84K | Buy |
1,832
+1,316
| +255% | +$60.3K | ﹤0.01% | 1380 |
|
|
2015
Q2 | $17K | Hold |
516
| – | – | ﹤0.01% | 1416 |
|
|
2015
Q1 | $16K | Hold |
516
| – | – | ﹤0.01% | 1406 |
|
|
2014
Q4 | $19K | Buy |
+516
| New | +$19K | ﹤0.01% | 1397 |
|
|
2014
Q3 | – | Sell |
-1,145
| Closed | -$34K | – | 1537 |
|
|
2014
Q2 | $34K | Hold |
1,145
| – | – | ﹤0.01% | 1121 |
|
|
2014
Q1 | $42K | Sell |
1,145
-470
| -29% | -$17.2K | ﹤0.01% | 1141 |
|
|
2013
Q4 | $67K | Buy |
+1,615
| New | +$67K | ﹤0.01% | 1209 |
|